OtherClinical Investigations
Somatostatin Receptor Scintigraphy in Liver Metastasis Detection from Gastroenteropancreatic Neuroendocrine Tumors
Orazio Schillaci, Angela Spanu, Francesco Scopinaro, Antonio Falchi, Roberta Danieli, Pietro Marongiu, Nicola Pisu, Giordano Madeddu, Gianfranco Delle Fave and Giuseppe Madeddu
Journal of Nuclear Medicine March 2003, 44 (3) 359-368;
Orazio Schillaci
Angela Spanu
Francesco Scopinaro
Antonio Falchi
Roberta Danieli
Pietro Marongiu
Nicola Pisu
Giordano Madeddu
Gianfranco Delle Fave
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Somatostatin Receptor Scintigraphy in Liver Metastasis Detection from Gastroenteropancreatic Neuroendocrine Tumors
Orazio Schillaci, Angela Spanu, Francesco Scopinaro, Antonio Falchi, Roberta Danieli, Pietro Marongiu, Nicola Pisu, Giordano Madeddu, Gianfranco Delle Fave, Giuseppe Madeddu
Journal of Nuclear Medicine Mar 2003, 44 (3) 359-368;
Somatostatin Receptor Scintigraphy in Liver Metastasis Detection from Gastroenteropancreatic Neuroendocrine Tumors
Orazio Schillaci, Angela Spanu, Francesco Scopinaro, Antonio Falchi, Roberta Danieli, Pietro Marongiu, Nicola Pisu, Giordano Madeddu, Gianfranco Delle Fave, Giuseppe Madeddu
Journal of Nuclear Medicine Mar 2003, 44 (3) 359-368;
Related Articles
- No related articles found.
Cited By...
- Evaluation of a Correction Method for 111In-Pentetreotide SPECT Imaging of Gastroenteropancreatic Neuroendocrine Tumors
- Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
- Gluc-Lys([18F]FP)-TOCA PET in Patients with SSTR-Positive Tumors: Biodistribution and Diagnostic Evaluation Compared with [111In]DTPA-Octreotide
- Factors Predicting Tracer Uptake in Somatostatin Receptor and MIBG Scintigraphy of Metastatic Gastroenteropancreatic Neuroendocrine Tumors
- Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours
- Detection of Liver Metastases From Endocrine Tumors: A Prospective Comparison of Somatostatin Receptor Scintigraphy, Computed Tomography, and Magnetic Resonance Imaging